Arradial develops microfluidics-based drug discovery technology

History:

Arradial was formed as a spinout from Alexion Pharmaceuticals. Unable to raise money in a down IPO market, they were acquired by BioProcessors.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northeast

Research Focus:
Microarray/Chip Technologies Disease Therapeutics-Research

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: